Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Sanjay Popat
Based on 14 articles published since 2007
||||
Expertise Level
The expertise of Sanjay Popat ranks in the
  • Top 0.31%
  • ... of 16,055 published authors worldwide on Mesothelioma
  • ... from 2007 through 2018
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Popat, S   ·   Popat, Sanjay
Work Locations
Details
Most likely:    Royal Marsden Hospital and Trust      
2017
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Erasmus MC Cancer Institute, 3015 CE Rotterdam, The Netherlands. · Royal Marsden Hospital, London SW3 6JJ, UK. · National Heart and Lung Institute, Imperial College London SW3 6NP, UK. · University of Leicester, Leicester LE1 9HN, UK. · Pubmed 28740119
  • Department of Oncology, University of Turin, S Luigi Hospital, Torino, Italy. Electronic address: · National Cancer Institute, Cairo University, Cairo, Egypt. · School of Medicine, Faculty of Medicine and Health Sciences, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany. · Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium. · US Oncology Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. · Boehringer Ingelheim (Canada) Ltd/Ltée, Burlington, Ontario, Canada. · Boehringer Ingelheim France S.A.S., Paris, France. · Royal Marsden Hospital NHS Foundation Trust, London and Surrey, United Kingdom. · Pubmed 28690011
  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. · Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. Electronic address: · Pubmed 28214659
2016
  • Medical Oncology Department, Arnau de Vilanova University Hospital, Avda. Rovira Roure, 80, 25198, Lleida, Spain. · Lung Cancer Unit, Royal Marsden Hospital, London, UK. · Pubmed 26680633
2014
  • Royal Marsden Hospital, Fulham Road, SW3 6JJ London, Surrey, UK. · Pubmed 25227779
2017
  • Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Pubmed 28892431
2013
  • The Royal Marsden NHS Foundation, Downs Road, Sutton, Surrey SM2 5PT, United Kingdom. · Pubmed 23791541
2008
  • Lung Unit, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, Surrey, United Kingdom. · Pubmed 18449011
2007
  • Department of Medical Oncology, Royal Marsden Hospital, Sutton, SURREY SM2 5PT, United Kingdom. · Pubmed 17400330
Probable:    University of London      
2017
  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. · Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. Electronic address: · Pubmed 28214659
2017
  • Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Pubmed 28892431
Probable:    Imperial College      
2017
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Erasmus MC Cancer Institute, 3015 CE Rotterdam, The Netherlands. · Royal Marsden Hospital, London SW3 6JJ, UK. · National Heart and Lung Institute, Imperial College London SW3 6NP, UK. · University of Leicester, Leicester LE1 9HN, UK. · Pubmed 28740119
  • The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK. · Surrey and Sussex Healthcare NHS Trust, Surrey, UK. · Molecular Genetics and Genomics Group, Imperial College London, London, UK. · Pubmed 26556778
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Sanjay Popat about Mesothelioma:

  • Novel insights into mesothelioma biology and implications for therapy. 2017
  • Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial. 2017
  • LUME-Meso: Design and Rationale of the Phase III Part of a Placebo-Controlled Study of Nintedanib and Pemetrexed/Cisplatin Followed by Maintenance Nintedanib in Patients With Unresectable Malignant Pleural Mesothelioma. 2017
  • Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit. 2017
  • A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic. 2017
  • Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases. 2016
  • A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma. 2016
  • Response evaluation in mesothelioma: Beyond RECIST. 2015
  • A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice. 2014
  • Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052). 2013
Show List of Full Article Records
Google Searches

Learn more about Sanjay Popat using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Royal Marsden Hospital and Trust
University of London
Imperial College
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Royal Marsden Hospital and Trust
2017
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Erasmus MC Cancer Institute, 3015 CE Rotterdam, The Netherlands. · Royal Marsden Hospital, London SW3 6JJ, UK. · National Heart and Lung Institute, Imperial College London SW3 6NP, UK. · University of Leicester, Leicester LE1 9HN, UK. · Pubmed 28740119
  • Department of Oncology, University of Turin, S Luigi Hospital, Torino, Italy. Electronic address: · National Cancer Institute, Cairo University, Cairo, Egypt. · School of Medicine, Faculty of Medicine and Health Sciences, University of Western Australia, Crawley, Western Australia, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. · Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany. · Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX. · Department of Thoracic Oncology, Antwerp University Hospital, Edegem, Belgium. · US Oncology Comprehensive Cancer Centers of Nevada, Las Vegas, NV. · Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan. · Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany. · Boehringer Ingelheim (Canada) Ltd/Ltée, Burlington, Ontario, Canada. · Boehringer Ingelheim France S.A.S., Paris, France. · Royal Marsden Hospital NHS Foundation Trust, London and Surrey, United Kingdom. · Pubmed 28690011
  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. · Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. Electronic address: · Pubmed 28214659
2016
  • Medical Oncology Department, Arnau de Vilanova University Hospital, Avda. Rovira Roure, 80, 25198, Lleida, Spain. · Lung Cancer Unit, Royal Marsden Hospital, London, UK. · Pubmed 26680633
2014
  • Royal Marsden Hospital, Fulham Road, SW3 6JJ London, Surrey, UK. · Pubmed 25227779
2017
  • Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Pubmed 28892431
2013
  • The Royal Marsden NHS Foundation, Downs Road, Sutton, Surrey SM2 5PT, United Kingdom. · Pubmed 23791541
2008
  • Lung Unit, The Royal Marsden Hospital, Downs Road, Sutton, Surrey, Surrey, United Kingdom. · Pubmed 18449011
2007
  • Department of Medical Oncology, Royal Marsden Hospital, Sutton, SURREY SM2 5PT, United Kingdom. · Pubmed 17400330
University of London
2017
  • Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. · Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London, United Kingdom. Electronic address: · Pubmed 28214659
2017
  • Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT. · Pubmed 28892431
Unspecified
2017
  • The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK. · Surrey and Sussex Healthcare NHS Trust, Surrey, UK. · Molecular Genetics and Genomics Group, Imperial College London, London, UK. · Pubmed 26556778
2016
  • Lung Unit, Royal Marsden Hospital, Sutton, UK. · Dept of Anaesthetics and Pain Management Royal Marsden Hospital, Sutton, UK. · Lung Unit, Royal Marsden Hospital, Sutton, UK. Electronic address: mary.o' · Pubmed 27156228
2015
  • EPSRC-CR UK Cancer Imaging Centre, Institute of Cancer Research, UK. · EPSRC-CR UK Cancer Imaging Centre, Institute of Cancer Research, UK; Department of Radiology, Royal Marsden Hospital, UK. · Department of Radiology, Royal Marsden Hospital, UK. · Department of Medical Oncology, Royal Marsden Hospital, UK. · EPSRC-CR UK Cancer Imaging Centre, Institute of Cancer Research, UK; Department of Radiology, Royal Marsden Hospital, UK. Electronic address: · Pubmed 26443279
2011
  • Dept Medical Oncology, Christie Hospital, Manchester M20 4BX, UK. · Pubmed 21334759
Imperial College
2017
  • The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Erasmus MC Cancer Institute, 3015 CE Rotterdam, The Netherlands. · Royal Marsden Hospital, London SW3 6JJ, UK. · National Heart and Lung Institute, Imperial College London SW3 6NP, UK. · University of Leicester, Leicester LE1 9HN, UK. · Pubmed 28740119
  • The Royal Marsden Hospital, NHS Foundation Trust, Sutton, UK. · Surrey and Sussex Healthcare NHS Trust, Surrey, UK. · Molecular Genetics and Genomics Group, Imperial College London, London, UK. · Pubmed 26556778
12 Other Locations Show
Yearly article counts 052112010011
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.